FRANKFURT Feb 29 German generic drugmaker Stada raised the prospect of a slight increase in adjusted profit this year after 2015 adjusted core earnings fell 10 percent as the low rouble weighed on the value of its sales in Russia.
Adjusted 2015 earnings before interest, taxes, depreciation and amortisation (EBITDA) fell 10 percent to 389.4 million euros ($424 million), Stada said in a statement on Monday, citing preliminary results.
07:15 Telefonica to sell up to 40 percent of Telxius to KKR for 1.3 billion euros22
17:21 Stocks mixed after Treasury Secretary points to significant tax reform; industrials lag24
05:12 Wednesday's Powerball Winning Numbers For $435 Million Jackpot22
09:51 Airbus takes new hit for A400M as core profit beats forecasts17